The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Patient-Reported Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer
Open accessAbstract
BACKGROUND: Robust data on patient-reported outcome measures comparing treatments for clinically localized prostate cancer are lacking. We investigated the effects of active monitoring, radical prostatectomy, and radical radiotherapy with hormones on patient-reported outcomes. METHODS: We compared patient-reported outcomes among 1643 men in the Prostate Testing for Cancer and Treatment (ProtecT) trial who completed questionnaires before diagnosis, at 6 and 12 months after randomization, and annually thereafter. Patients completed validated measures that assessed urinary, bowel, and sexual function and specific effects on quality of life, anxiety and depression, and general health. Cancer-related quality of life was assessed at 5 years. Complete 6-year data were analyzed according to the intention-to-treat principle. RESULTS: The rate of questionnaire completion during follow-up was higher than 85% for most measures. Of the three treatments, prostatectomy had the greatest negative effect on sexual function and urinary continence, and although there was some recovery, these outcomes remained worse in the prostatectomy group than in the other groups throughout the trial. The negative effect of radiotherapy on sexual function was greatest at 6 months, but sexual function then recovered somewhat and was stable thereafter; radiotherapy had little effect on urinary continence. Sexual and urinary function declined gradually in the active-monitoring group. Bowel function was worse in the radiotherapy group at 6 months than in the other groups but then recovered somewhat, except for the increasing frequency of bloody stools; bowel function was unchanged in the other groups. Urinary voiding and nocturia were worse in the radiotherapy group at 6 months but then mostly recovered and were similar to the other groups after 12 months. Effects on quality of life mirrored the reported changes in function. No significant differences were observed among the groups in measures of anxiety, depression, or general health-related or cancer-related quality of life. CONCLUSIONS: In this analysis of patient-reported outcomes after treatment for localized prostate cancer, patterns of severity, recovery, and decline in urinary, bowel, and sexual function and associated quality of life differed among the three groups. (Funded by the U.K. National Institute for Health Research Health Technology Assessment Program; ProtecT Current Controlled Trials number, ISRCTN20141297 ; ClinicalTrials.gov number, NCT02044172 .).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Hospital Anxiety and Depression Scale
Zigmond, A. S., & Snaith, R. P. (1983) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1983.tb09716.x · Cited by 47,139
Aaronson, N. K., Ahmedzai, S., Bergman, B., Bullinger, M., Cull, A., Duez, N. J., Filiberti, A., Flechtner, H., Fleishman, S. B., Haes, J. C. J. M. D., et al. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.5.365 · Cited by 16,005
Depression and quality of life in older persons: A review
Sivertsen, H., Bjørkløf, G. H., Engedal, K., Selbæk, G., & Helvik, A.-S. (2015) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000437299 · Cited by 14,152
RUBIN, D. B. (1976) · Biometrika · doi:10.1093/biomet/63.3.581 · Cited by 9,925
Screening and Prostate-Cancer Mortality in a Randomized European Study
Schröder, F. H., Hugosson, J., Roobol, M. J., Tammela, T. L. J., Ciatto, S., Nelen, V., Kwiatkowski, M., Lujan, M., Lilja, H., Zappa, M., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810084 · Cited by 4,014
Cross-Validation of Item Selection and Scoring for the SF-12 Health Survey in Nine Countries
Gandek, B., Ware, J. E., Aaronson, N. K., Apolone, G., Bjorner, J. B., Brazier, J. E., Bullinger, M., Kaasa, S., Leplege, A., Prieto, L., et al. (1998) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(98)00109-7 · Cited by 2,907
Mortality Results from a Randomized Prostate-Cancer Screening Trial
Andriole, G. L., Crawford, E. D., Grubb, R. L., Buys, S. S., Chia, D., Church, T. R., Fouad, M. N., Gelmann, E. P., Kvale, P. A., Reding, D. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810696 · Cited by 2,906
10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer
Hamdy, F. C., Donovan, J. L., Lane, J. A., Mason, M., Metcalfe, C., Holding, P., Davis, M., Peters, T. J., Turner, E. L., Martin, R. M., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1606220 · Cited by 2,640
Self-citationQuality of Life and Satisfaction with Outcome among Prostate-Cancer Survivors
Sanda, M. G., Dunn, R. L., Michalski, J., Sandler, H. M., Northouse, L., Hembroff, L., Lin, X., Greenfield, T. K., Litwin, M. S., Saigal, C. S., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa074311 · Cited by 2,253
ICIQ: A brief and robust measure for evaluating the symptoms and impact of urinary incontinence
Avery, K., Donovan, J., Peters, T. J., Shaw, C., Gotoh, M., & Abrams, P. (2004) · Neurourology and Urodynamics · doi:10.1002/nau.20041 · Cited by 1,972
Self-citationRadical Prostatectomy versus Observation for Localized Prostate Cancer
Wilt, T. J., Brawer, M. K., Jones, K. M., Barry, M. J., Aronson, W. J., Fox, S., Gingrich, J. R., Wei, J. T., Gilhooly, P., Grob, B. M., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1113162 · Cited by 1,770
Wei, J. T., Dunn, R. L., Litwin, M. S., Sandler, H. M., & Sanda, M. G. (2000) · Urology · doi:10.1016/s0090-4295(00)00858-x · Cited by 1,520
Reporting of Patient-Reported Outcomes in Randomized Trials: The CONSORT PRO Extension
Calvert, M., Blazeby, J., Altman, D. G., Revicki, D. A., Moher, D., Brundage, M. D., & CONSORT PRO Group, F. T. (2013) · JAMA · doi:10.1001/jama.2013.879 · Cited by 1,386
Self-citationLong-Term Functional Outcomes after Treatment for Localized Prostate Cancer
Resnick, M. J., Koyama, T., Fan, K.-H., Albertsen, P. C., Goodman, M., Hamilton, A. S., Hoffman, R. M., Potosky, A. L., Stanford, J. L., Stroup, A. M., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1209978 · Cited by 979
Quality of Life after Radical Prostatectomy or Watchful Waiting
Steineck, G., Helgesen, F., Adolfsson, J., Dickman, P. W., Johansson, J.-E., Norlén, B. J., & Holmberg, L. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021483 · Cited by 722
Yaxley, J. W., Coughlin, G. D., Chambers, S. K., Occhipinti, S., Samaratunga, H., Zajdlewicz, L., Dunglison, N., Carter, R., Williams, S., Payton, D. J., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)30592-x · Cited by 715
Wilt, T. J., MacDonald, R., Rutks, I., Shamliyan, T. A., Taylor, B. C., & Kane, R. L. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-148-6-200803180-00209 · Cited by 597
Screening for Prostate Cancer: A Review of the Evidence for the U.S. Preventive Services Task Force
Chou, R., Croswell, J. M., Dana, T., Bougatsos, C., Blazina, I., Fu, R., Gleitsmann, K., Koenig, H. C., Lam, C., Maltz, A., et al. (2011) · Annals of Internal Medicine · doi:10.7326/0003-4819-155-11-201112060-00375 · Cited by 573
Tewari, A., Sooriakumaran, P., Bloch, D. A., Seshadri-Kreaden, U., Hebert, A. E., & Wiklund, P. (2012) · European Urology · doi:10.1016/j.eururo.2012.02.029 · Cited by 519
Wei, J. T., Dunn, R. L., Sandler, H. M., McLaughlin, P. W., Montie, J. E., Litwin, M. S., NYQUIST, L. V., & Sanda, M. G. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.2.557 · Cited by 443
Andriole, G. L. (2012) · Yearbook of Urology · doi:10.1016/j.yuro.2012.07.016 · Cited by 406
Johansson, E., Steineck, G., Holmberg, L., Johansson, J.-E., Nyberg, T., Ruutu, M., & Bill-Axelson, A. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70162-0 · Cited by 360
Recommended Patient-Reported Core Set of Symptoms to Measure in Adult Cancer Treatment Trials
Reeve, B. B., Mitchell, S. A., Dueck, A. C., Basch, E., Cella, D., Reilly, C. M., Minasian, L. M., Denicoff, A. M., O'Mara, A. M., Fisch, M. J., et al. (2014) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dju129 · Cited by 350
Smith, D. P., King, M. T., Egger, S., Berry, M. P., Stricker, P. D., Cozzi, P., Ward, J., O'Connell, D. L., & Armstrong, B. K. (2009) · BMJ · doi:10.1136/bmj.b4817 · Cited by 286
Defining a Standard Set of Patient-centered Outcomes for Men with Localized Prostate Cancer
Martin, N. E., Massey, L., Stowell, C., Bangma, C., Briganti, A., Bill-Axelson, A., Blute, M., Catto, J., Chen, R. C., D’Amico, A. V., et al. (2015) · European Urology · doi:10.1016/j.eururo.2014.08.075 · Cited by 239
Self-citationLane, J. A., Donovan, J. L., Davis, M., Walsh, E., Dedman, D., Down, L., Turner, E. L., Mason, M. D., Metcalfe, C., Peters, T. J., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70361-4 · Cited by 231
Self-citationBarry, M. J., Gallagher, P. M., Skinner, J. S., & Fowler, F. J. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.36.8621 · Cited by 177
Donovan, J., Lane, J. A., Peters, T. J., Brindle, L. A., Salter, E., Gillatt, D. A., Powell, P. H., Bollina, P. R., Neal, D. E., & Hamdy, F. C. (2008) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2008.02.010 · Cited by 159
Self-citationHow Does Active Surveillance for Prostate Cancer Affect Quality of Life? A Systematic Review
Bellardita, L., Valdagni, R., van den Bergh, R. C. N., Randsdorp, H., Repetto, C., Venderbos, L. D. F., Lane, J. A., & Korfage, I. J. (2014) · European Urology · doi:10.1016/j.eururo.2014.10.028 · Cited by 132
Self-citationSimpkin, A. J., Tilling, K. M., Martin, R. M., Lane, J. A., Hamdy, F. C., Holmberg, L., Neal, D. E., Metcalfe, C., & Donovan, J. (2015) · European Urology · doi:10.1016/j.eururo.2015.01.004 · Cited by 115
Self-citationParker, P. A., Davis, J. W., Latini, D. M., Baum, G. P., Wang, X., Ward, J. F., Kuban, D., Frank, S. J., Lee, A. K., Logothetis, C. J., et al. (2015) · British Journal of Urology · doi:10.1111/bju.13099 · Cited by 112
Chou, R., & Croswell, J. M. (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-156-7-201204030-00017 · Cited by 108
Recommended Patient-Reported Core Set of Symptoms to Measure in Prostate Cancer Treatment Trials
Chen, R. C., Chang, P., Vetter, R. J., Lukka, H., Stokes, W. A., Sanda, M. G., Bruner, D. W., Reeve, B. B., & Sandler, H. M. (2014) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dju132 · Cited by 103
Bill‐Axelson, A., Garmo, H., Holmberg, L., Johansson, J., Adami, H., Steineck, G., Johansson, E., & Rider, J. R. (2013) · European Urology · doi:10.1016/j.eururo.2013.02.025 · Cited by 88
Whiting, P. F., Moore, T. H., Jameson, C., Davies, P. A., Rowlands, M., Burke, M., Beynon, R., Savović, J., & Donovan, J. (2016) · British Journal of Urology · doi:10.1111/bju.13499 · Cited by 82
Self-citationWilliams, N. J., Hughes, L., Turner, E. L., et al. (2011) · British Journal of Urology · doi:10.1111/j.1464-410x.2011.10163.x · Cited by 75
Self-citationLane, J. A., Metcalfe, C., Young, G., Peters, T. J., Blazeby, J. M., AVERY, K. N. L., Dedman, D., Down, L., Mason, M. D., Neal, D. E., et al. (2016) · British Journal of Urology · doi:10.1111/bju.13582 · Cited by 69
Self-citationMacLennan, S., Bekema, H. J., Williamson, P. R., Campbell, M., Stewart, F. J., MacLennan, S. J., N’Dow, J., & Lam, T. B. L. (2015) · Trials · doi:10.1186/s13063-015-0598-0 · Cited by 57
Buckley, B. S., Lapitan, M. C., Glazener, C. M. A., & for the MAPS Trial Group (2012) · Neurourology and Urodynamics · doi:10.1002/nau.21231 · Cited by 44
the CAP trial group, Turner, E. L., Metcalfe, C., Donovan, J., Noble, S., Sterne, J. A. C., Lane, J. A., AVERY, K. N. L., Down, L., Walsh, E. I., et al. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.242 · Cited by 31
Self-citationLane, J. A., Wade, J., Down, L., Bonnington, S., Holding, P., Lennon, T., Jones, A. J., Salter, C. E., Neal, D. E., Hamdy, F. C., et al. (2011) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2010.10.003 · Cited by 21
Self-citation
Cited by
Mottet, N., van den Bergh, R. C. N., Briers, E., Van den Broeck, T., Cumberbatch, M. G., De Santis, M., Fanti, S., Fossati, N., Gandaglia, G., Gillessen, S., et al. (2021) · European Urology · doi:10.1016/j.eururo.2020.09.042 · Cited by 2,802
Self-citation10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer
Hamdy, F. C., Donovan, J. L., Lane, J. A., Mason, M., Metcalfe, C., Holding, P., Davis, M., Peters, T. J., Turner, E. L., Martin, R. M., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1606220 · Cited by 2,640
Self-citationScreening for Prostate Cancer: US Preventive Services Task Force Recommendation Statement
US Preventive Services Task Force, Grossman, D. C., Curry, S. J., Owens, D. K., Bibbins-Domingo, K., Caughey, A. B., Davidson, K. W., Doubeni, C. A., Ebell, M., Epling, J. W., et al. (2018) · JAMA · doi:10.1001/jama.2018.3710 · Cited by 1,436
The Diagnosis and Treatment of Prostate Cancer: A Review
Litwin, M. S., & Tan, H.-J. (2017) · JAMA · doi:10.1001/jama.2017.7248 · Cited by 1,435
Rebello, R. J., Oing, C., Knudsen, K. E., Loeb, S., Johnson, D. C., Reiter, R. E., Gillessen, S., Van der Kwast, T., & Bristow, R. G. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-00243-0 · Cited by 1,090
Metadata
- Authors
- Donovan, J. L., Hamdy, F. C., Lane, J. A., Mason, M., Metcalfe, C., Walsh, E., Blazeby, J. M., Peters, T. J., Holding, P., Bonnington, S., Lennon, T., Bradshaw, L., Cooper, D., Herbert, P., Howson, J., Jones, A., Lyons, N., Salter, E., Thompson, P., Tidball, S., Blaikie, J., Gray, C., Bollina, P., Catto, J., Doble, A., Doherty, A., Gillatt, D., Kockelbergh, R., Kynaston, H., Paul, A., Powell, P., Prescott, S., Rosario, D. J., Rowe, E., Davis, M., Turner, E. L., Martin, R. M., & Neal, D. E.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2016-10-13
- Volume
- 375
- Issue
- 15
- Pages
- 1425-1437
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2519027667
- Cited by
- 1,338
- References
- 41
- FWCI
- 130.56
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.